Skip to content
PINC-AI™ Login or Register

Stemming The Spread of COVID-19

For the first time in 50 years, the Centers for Disease Control and Prevention mandates quarantine for travelers from China due to an outbreak of respiratory illness caused by a novel (new) coronavirus - COVID-19 - first identified in Wuhan,…

Read more

TheraDoc v4.6.1 Hardware and Software Requirements

Download TheraDoc v4.6.1 Hardware and Software Requirements PDF In preparation for the release of TheraDoc® v4.6.1, we have the following important information to communicate. Client Workstation Browser Requirements Supported Browsers Due to performance related issues, the use of Microsoft Internet…

Read more

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions. TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier's board of directors unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117 million represents a purchase price multiple in the 10-11 times range.
Read more
Back To Top